What is the address of DR. EVIE BARBE, ANESTHESIE?

The registered office of DR. EVIE BARBE, ANESTHESIE is located at Graaf de Thienneslaan 9, 8800 Roeselare.

Is DR. EVIE BARBE, ANESTHESIE still active?

Yes. According to the CBE (2 October 2026) DR. EVIE BARBE, ANESTHESIE is active, legal situation “Normale toestand”, started on 11 January 2012.

Is DR. EVIE BARBE, ANESTHESIE registered on Peppol?

No, DR. EVIE BARBE, ANESTHESIE is currently not registered on the Peppol network.

What is the enterprise number of DR. EVIE BARBE, ANESTHESIE?

The enterprise number of DR. EVIE BARBE, ANESTHESIE is BE0842965830.

When was DR. EVIE BARBE, ANESTHESIE founded?

DR. EVIE BARBE, ANESTHESIE was founded on 11 January 2012.

Who are the directors of DR. EVIE BARBE, ANESTHESIE?

According to the 2025 annual accounts, the directors of DR. EVIE BARBE, ANESTHESIE are: Evie BARBE.

Is DR. EVIE BARBE, ANESTHESIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 January 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. EVIE BARBE, ANESTHESIE make in 2025?

DR. EVIE BARBE, ANESTHESIE posted a profit after taxes of € 252,028 in financial year 2025.

What is the revenue of DR. EVIE BARBE, ANESTHESIE?

As a small company, DR. EVIE BARBE, ANESTHESIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 353,607.

DR. EVIE BARBE, ANESTHESIE (Private Limited) - Roeselare

Dossier DR. EVIE BARBE, ANESTHESIE, printed on 2 October 2026 from databakkes.be/en/0842965830/dr-evie-barbe-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. EVIE BARBE, ANESTHESIE from Roeselare, company number BE0842965830, closed financial year 2025 with a result of € 252,028 after tax. For that financial year DR. EVIE BARBE, ANESTHESIE recorded a gross margin of € 353,607 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 190,206 to € 252,028. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 1.1 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 252,028

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 193,231

▲ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 125,526 paid out

50 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

€ 180,000

▲ 13% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,701

▲ 203% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 62,579

▲ 223% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 234,769 Gross margin 2022: € 234,769 First fiscal year in the series	€ 233,637 Gross margin 2023: € 233,637 Unchanged (€ 234,769) Unfavourable step	€ 281,900 Gross margin 2024: € 281,900 ▲ 21% vs 2023 (€ 233,637) Favourable step	€ 353,607 Gross margin 2025: € 353,607 ▲ 25% vs 2024 (€ 281,900) Favourable step	▲ 25%
Profit after taxes	€ 170,350 Profit after taxes 2022: € 170,350 First fiscal year in the series	€ 154,914 Profit after taxes 2023: € 154,914 ▼ 9% vs 2022 (€ 170,350) Unfavourable step	€ 190,206 Profit after taxes 2024: € 190,206 ▲ 23% vs 2023 (€ 154,914) Favourable step	€ 252,028 Profit after taxes 2025: € 252,028 ▲ 33% vs 2024 (€ 190,206) Favourable step	▲ 33%
Equity	€ 746,335 Equity 2022: € 746,335 First fiscal year in the series	€ 901,249 Equity 2023: € 901,249 ▲ 21% vs 2022 (€ 746,335) Favourable step	€ 990,482 Equity 2024: € 990,482 ▲ 10% vs 2023 (€ 901,249) Favourable step	€ 1,116,984 Equity 2025: € 1,116,984 ▲ 13% vs 2024 (€ 990,482) Favourable step	▲ 13%
Total debts	€ 331,486 Total debts 2022: € 331,486 First fiscal year in the series	€ 173,873 Total debts 2023: € 173,873 ▼ 48% vs 2022 (€ 331,486) Favourable step	€ 199,557 Total debts 2024: € 199,557 ▲ 15% vs 2023 (€ 173,873) Unfavourable step	€ 260,931 Total debts 2025: € 260,931 ▲ 31% vs 2024 (€ 199,557) Unfavourable step	▲ 31%
Cash	€ 39,337 Cash 2022: € 39,337 First fiscal year in the series	€ 130,170 Cash 2023: € 130,170 ▲ 231% vs 2022 (€ 39,337) Favourable step	€ 131,303 Cash 2024: € 131,303 ▲ 1% vs 2023 (€ 130,170) Favourable step	€ 193,231 Cash 2025: € 193,231 ▲ 47% vs 2024 (€ 131,303) Favourable step	▲ 47%
Retained profit	€ 727,735 Retained profit 2022: € 727,735 First fiscal year in the series	€ 882,649 Retained profit 2023: € 882,649 ▲ 21% vs 2022 (€ 727,735) Favourable step	€ 971,882 Retained profit 2024: € 971,882 ▲ 10% vs 2023 (€ 882,649) Favourable step	€ 1,098,384 Retained profit 2025: € 1,098,384 ▲ 13% vs 2024 (€ 971,882) Favourable step	▲ 13%
Dividend	€ 137,512 Dividend 2022: € 137,512 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 137,512) Unchanged	€ 100,973 Dividend 2024: € 100,973 Unchanged (€ 0) Unchanged	€ 125,526 Dividend 2025: € 125,526 ▲ 24% vs 2024 (€ 100,973) Unchanged	▲ 24%
Bank debt	€ 142,000 Bank debt 2022: € 142,000 First fiscal year in the series	€ 154,000 Bank debt 2023: € 154,000 ▲ 8% vs 2022 (€ 142,000) Unfavourable step	€ 160,000 Bank debt 2024: € 160,000 ▲ 4% vs 2023 (€ 154,000) Unfavourable step	€ 180,000 Bank debt 2025: € 180,000 ▲ 13% vs 2024 (€ 160,000) Unfavourable step	▲ 13%
Balance sheet total	€ 1,077,821 Balance sheet total 2022: € 1,077,821 First fiscal year in the series	€ 1,075,122 Balance sheet total 2023: € 1,075,122 Unchanged (€ 1,077,821) Unchanged	€ 1,190,039 Balance sheet total 2024: € 1,190,039 ▲ 11% vs 2023 (€ 1,075,122) Unchanged	€ 1,377,915 Balance sheet total 2025: € 1,377,915 ▲ 16% vs 2024 (€ 1,190,039) Unchanged	▲ 16%

Key figures of DR. EVIE BARBE, ANESTHESIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. EVIE BARBE, ANESTHESIE?

What happened at DR. EVIE BARBE, ANESTHESIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 252,028 (▲ 33% vs 2024). Source: NBB ↗
Jan 31, 2012 New establishment in Roeselare. KBO
Jan 11, 2012 Start of the company according to the CBE. KBO

In short

From € 170,350 profit in 2022 to € 252,028 profit in 2025.

Paid € 361,878 in corporate taxes since 2022.

Best year ever: 2025, with € 252,028 profit.

Paid out € 364,011 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. EVIE BARBE, ANESTHESIE? We notify you, reason included.

Follow DR. EVIE BARBE, ANESTHESIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Evie BARBE

DR. EVIE BARBE, ANESTHESIE

Behind DR. EVIE BARBE, ANESTHESIE is Evie BARBE.

See the full network in the app

Directors

According to the 2025 annual accounts

Evie BARBE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Graaf de Thienneslaan 9

8800 Roeselare

2.206.320.923

Brugsesteenweg 90

8800 Roeselare

Active since 31 January 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0842.965.830
VAT number: BE 0842.965.830
Registered office: Graaf de Thienneslaan 9, 8800 Roeselare
Names & denominations: DR. EVIE BARBE, ANESTHESIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 January 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗